A detailed history of Kopp Le Roy C transactions in Vericel Corp stock. As of the latest transaction made, Kopp Le Roy C holds 457,615 shares of VCEL stock, worth $26.2 Million. This represents 13.6% of its overall portfolio holdings.

Number of Shares
457,615
Holding current value
$26.2 Million
% of portfolio
13.6%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 03, 2024

BUY
$32.52 - $52.33 $14.9 Million - $23.9 Million
457,615 New
457,615 $23.8 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Kopp Le Roy C Portfolio

Follow Kopp Le Roy C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kopp Le Roy C, based on Form 13F filings with the SEC.

News

Stay updated on Kopp Le Roy C with notifications on news.